AWD 140-190: A new anticonvulsant with a very good margin of safety

Epilepsy Research

Volumn 28, Issue 1, 1997, Pages 17-28

  Rostock, Angelika ^a   Tober, Christine ^a   Rundfeldt, Chris ^a   Bartsch, Reni ^a   Unverferth, Klaus ^a   Engel, Jürgen ^a   Wolf, Harold H ^b   White, H Steve ^b  

^a ASTA MEDICA AG   (Germany)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Anticonvulsant; AWD 140 190; Learning; Protective Index

Indexed keywords

ANTICONVULSIVE AGENT; AWD 140190; BICUCULLINE; CARBAMAZEPINE; PENTETRAZOLE; PHENYTOIN; STRYCHNINE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; EXPERIMENTAL MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE; TASK PERFORMANCE;

ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; MALE; MICE; MORPHOLINES; PHENYTOIN; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; VALPROIC ACID;

EID: 0030792225     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(97)00023-5     Document Type: Article

References (16)

1. Dam M. Intractable epilepsy: Introduction. In: Schmidt D, Morselli PL, editors. Intractable Epilepsy: Experimental and Clinical Aspects. New York, NY: Raven Press, 1986:1-3.
2. Kimball AW, Burnett WT, Doherty DG. Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 1957;7:1-12.
3. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99-113.
4. Loiseau P. Do we need novel anti-epileptic drugs? Br J Clin Pract 1988;42:2-3.
5. Rostock A, Rundfeldt C, Tober C, Bartsch R. AWD 140-190: A new anticonvulsant with sodium channel blocking properties. Soc Neurosci Abstr 1995;21:203.
6. Rostock A, Tober C, Seidel B, Bartsch R. Anticonvulsant activity and plasma concentration of AWD 140-190 in rats. Epilepsia 1995;36(Suppl 4):50.
7. Rundfeldt C, Wlaz P, Hönack D, Löscher W. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil. J Pharmacol Exp Ther 1996;275:693-702.
8. Sander JW, Shorvon SD. Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry 1987;50:829-39.
9. Schmidt D. Anticonvulsants. In: Dukes MNG, editor. Meyler's Side Effects of Drugs, 12th Edition. Amsterdam: Elsevier Science, 1992:122-143.
10. Schmidt D, Morselli PL, editors. Intractable Epilepsy: Experimental and Clinical Aspects. New York: Raven Press, 1986.
11. Swinyard EA. Laboratory evaluation of antiepileptic drugs. Review of laboratory methods. Epilepsia 1969;10:107-19.
12. Swinyard EA, Wolf HH, White S, Skeen GA, Stark LG, Albertson T, Pong SF, Drust EG. Characterisation of the anticonvulsant properties of F-721. Epilepsy Res 1993;15:35-45.
13. Tober C, Jainta H, Rundfeldt C, Rostock A, Bartsch R. Anticonvulsant and antiepileptogenic effects of D-23129 in the kindling model of focal epilepsy. Naunyn-Schmiedeberg's Arch Pharmacol 1995;351(Suppl):R160.
14. Tober C, Rostock A, Rundfeldt C, Bartsch R. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur J Pharmacol 1996;303:163-9.
15. Unverferth K, Lankau H-J, Günther R, Rostock A, Rundfeldt C. Synthesis and anticonvulsant activity of 3-aminipyrroles. In: IBC's International Conference on Epilepsia, 5-6 Febr. 1996, Orlando, FL.
16. White HS, Wolf HH, Swinyard A, Skeen GA, Sofia RD. A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia 1992;33:564-72.